Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,458 shares at $215.56 ($1.8M) on 2021-02-25, disclosed to the SEC on 2021-02-26.
Seasonal sale ($1.8M) by EVP, Chief Patient Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $217.57 | 2,946 | $641K | 35.3% |
| 2 | $211.56 | 922 | $195K | 10.7% |
| 3 | $211.56 | 922 | $195K | 10.7% |
| 4 | $213.30 | 1,460 | $311K | 17.1% |
| 5 | $214.19 | 668 | $143K | 7.9% |
| 6 | $214.19 | 668 |
| $143K |
| 7.9% |
| 7 | $215.56 | 336 | $72K | 4.0% |
| 8 | $215.56 | 336 | $72K | 4.0% |
| 9 | $216.62 | 200 | $43K | 2.4% |
| Total | $214.81 avg | 8,458 | $1.8M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |